Chengcai Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Chengcai Li has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Bo Jia
Department of Neurosurgery,The First Hospital of Hebei Medical University, PR China
1 shared publication Chunliang Wang
Department of Neurosurgery, The 1st Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China
1 shared publicationHeqiang Yang
Department of Trauma and Acute Care Surgery, The 1st Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China
1 shared publication- Huaxin Zhu
Department of Neurosurgery, The First Affiliated Hospital of Nanchang University, Nanchang, People’s Republic of China
1 shared publication - Jie Tang
Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China
1 shared publication - Jiwei Wang
Department of Neurosurgery,The First Hospital of Hebei Medical University, PR China
1 shared publication
Latest Publications
- Open Access
- 25 October 2025
- Published by Elsevier in World Neurosurgery
- Vol. 204, 124597
Multidimensional Analysis of the Ability of Magnetic Resonance Imaging Variables and Peripheral White Blood Cells to Predict Neurological Impairment Following Acute Traumatic Cervical Spinal Cord Injury
- 25 October 2025
- Published by Elsevier in World Neurosurgery
- Vol. 204, 124597
Open AccessMultidimensional Analysis of the Ability of Magnetic Resonance Imaging Variables and Peripheral White Blood Cells to Predict Neurological Impairment Following Acute Traumatic Cervical Spinal Cord Injury
- Open Access
- 6 September 2024
- Published by Springer Nature in Discover Oncology
- Vol. 15 (1) , 1-13
Unveiling the role of PSMA5 in glioma progression and prognosis
Glioma is the most aggressive intracranial malignancy and is associated with poor survival rates and limited quality of life, impairing neuropsychological function and cognitive competence in survivors. The Proteasome Subunit Alpha Type-5 (PSMA5) is a multicatalytic proteinase complex that has been linked with tumor progression but is rarely reported in glioma. This study investigates the expression pattern, prognostic characteristics, and potential biological functions of PSMA5 in glioma. PSMA5 was significantly overexpressed in 28 types of cancer when compared to normal tissue. Furthermore, elevated levels of PSMA5 were observed in patients with wild-type isocitrate dehydrogenase 1 and exhibited a positive correlation with tumor grade. It was also found to be a standalone predictor of outcomes in glioma patients. Additionally, inhibiting PSMA5-induced cell cycle arrest may provide a therapeutic option for glioma.
- 6 September 2024
- Published by Springer Nature in Discover Oncology
- Vol. 15 (1) , 1-13
Open AccessUnveiling the role of PSMA5 in glioma progression and prognosis
Glioma is the most aggressive intracranial malignancy and is associated with poor survival rates and limited quality of life, impairing neuropsychological function and cognitive competence in survivors. The Proteasome Subunit Alpha Type-5 (PSMA5) is a multicatalytic proteinase complex that has been linked with tumor progression but is rarely reported in glioma. This study investigates the expression pattern, prognostic characteristics, and potential biological functions of PSMA5 in glioma. PSMA5 was significantly overexpressed in 28 types of cancer when compared to normal tissue. Furthermore, elevated levels of PSMA5 were observed in patients with wild-type isocitrate dehydrogenase 1 and exhibited a positive correlation with tumor grade. It was also found to be a standalone predictor of outcomes in glioma patients. Additionally, inhibiting PSMA5-induced cell cycle arrest may provide a therapeutic option for glioma.
- 7 April 2021
- Published by Springer Nature in Cellular and Molecular Neurobiology
- Vol. 42 (7) , 1-11
The Notch Signaling Pathway Regulates Differentiation of NG2 Cells into Oligodendrocytes in Demyelinating Diseases
NG2 cells are highly proliferative glial cells that can self-renew or differentiate into oligodendrocytes, promoting remyelination. Following demyelination, the proliferative and differentiation potentials of NG2 cells increase rapidly, enhancing their differentiation into functional myelinating cells. Levels of the transcription factors Olig1 and Olig2 increase during the differentiation of NG2 cells and play important roles in the development and repair of oligodendrocytes. However, the ability to generate new oligodendrocytes is hampered by injury-related factors (e.g., myelin fragments, Wnt and Notch signaling components), leading to failed differentiation and maturation of NG2 cells into oligodendrocytes. Here, we review Notch signaling as a negative regulator of oligodendrocyte differentiation and discuss the extracellular ligands, intracellular pathways, and key transcription factors involved.
- 7 April 2021
- Published by Springer Nature in Cellular and Molecular Neurobiology
- Vol. 42 (7) , 1-11
The Notch Signaling Pathway Regulates Differentiation of NG2 Cells into Oligodendrocytes in Demyelinating Diseases
NG2 cells are highly proliferative glial cells that can self-renew or differentiate into oligodendrocytes, promoting remyelination. Following demyelination, the proliferative and differentiation potentials of NG2 cells increase rapidly, enhancing their differentiation into functional myelinating cells. Levels of the transcription factors Olig1 and Olig2 increase during the differentiation of NG2 cells and play important roles in the development and repair of oligodendrocytes. However, the ability to generate new oligodendrocytes is hampered by injury-related factors (e.g., myelin fragments, Wnt and Notch signaling components), leading to failed differentiation and maturation of NG2 cells into oligodendrocytes. Here, we review Notch signaling as a negative regulator of oligodendrocyte differentiation and discuss the extracellular ligands, intracellular pathways, and key transcription factors involved.